{"title": "Indications for healthcare surge capacity in European countries facing an exponential increase in COVID19 cases", "doi": "10.1101/2020.03.14.20035980", "citation_id": "2020.03.14.20035980v1", "date": "2020-03-17", "laguage": "en", "journal_title": "medRxiv", "first_page": "2020.03.14.20035980", "abstract": "<p>European healthcare systems face rapidly increasing pressure from COVID-19. We calculated pressures on EU healthcare systems by relating both country-specific accumulated COVID-19 deaths (intensity-approach) and active COVID-19 cases (magnitude-approach) to various estimates of hospital beds. On March 14 2020 - relative to Italy on March 11- we found Spain, Luxembourg, Switzerland and France to experience the highest pressure using the intensity-approach, versus Iceland, Denmark, Norway, Sweden, Spain, Switzerland and Slovenia using the magnitude approach.</p>", "twitter_description": "European healthcare systems face rapidly increasing pressure from COVID-19. We calculated pressures on EU healthcare systems by relating both country-specific accumulated COVID-19 deaths (intensity-approach) and active COVID-19 cases (magnitude-approach) to various estimates of hospital beds. On March 14 2020 - relative to Italy on March 11- we found Spain, Luxembourg, Switzerland and France to experience the highest pressure using the intensity-approach, versus Iceland, Denmark, Norway, Sweden, Spain, Switzerland and Slovenia using the magnitude approach.\n\n### Competing Interest Statement\n\nThe authors have declared no competing interest.\n\n### Funding Statement\n\nThis work is funded by the Epipose project from the European Union\u0092s SC1- PHE-CORONAVIRUS-2020 programme, project number 101003688\n\n### Author Declarations\n\nAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.\n\nYes\n\nAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.\n\nYes\n\nI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).\n\nYes\n\nI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.\n\nYes\n\nThe data used in the article is publicly available and referred to in the main text.", "full_text_html_url": "https://www.medrxiv.org/content/10.1101/2020.03.14.20035980v1.full", "public_url": "https://www.medrxiv.org/content/10.1101/2020.03.14.20035980v1", "abstract_html_url": "https://www.medrxiv.org/content/10.1101/2020.03.14.20035980v1.abstract", "pdf_url": "https://www.medrxiv.org/content/medrxiv/early/2020/03/17/2020.03.14.20035980.full.pdf", "rights": "\u00a9 2020, Posted by Cold Spring Harbor Laboratory. This pre-print is available under a Creative Commons License (Attribution-NonCommercial 4.0 International), CC BY-NC 4.0, as described at http://creativecommons.org/licenses/by-nc/4.0/", "publisher": "Cold Spring Harbor Laboratory Press", "pisa": "medrxiv;2020.03.14.20035980v1", "access_rights": "restricted", "authors": ["Frederik Verelst", "Elise J. Kuylen", "Philippe Beutels"]}